Back Nauck, MA, Klein, N, rskov, C, et al (Aug 1993) 'Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients', Diabetologia , 36/8, 741-4
The simplified comparison is this: Semaglutide: GLP-1 receptor activity Tirzepatide: GIP and GLP-1 receptor activity Retatrutide: GIP, GLP-1, and glucagon receptor activity under clinical investigation More receptor activity does not automatically mean a medication is better for every patient
Hinke SA, Gelling RW, Pederson RA, et al
It simply means staying aware
In practical terms, they act as chemical messengers: they bind to receptors on cells, interact directly with proteins, or prompt the body to release a specific hormone, then let that hormone carry out the actual work
[12] [11] While prescription GLP-1 agonists deliver pharmacologic doses that produce measurable clinical effects, the magnitude of GLP-1 elevation from probiotic supplementsif anyis substantially lower and clinically uncertain